Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum
Su Yeon Park, Kyong Jin Shin(Inje University Haeundae Paik Hospital), Jung‐Joon Sung(Seoul National University), Kyomin Choi(Konkuk University), Jong‐Mok Lee(Konkuk University), Ha Young Shin(Yonsei University), Jin‐Hong Shin(Inje University Busan Paik Hospital), Tai‐Seung Nam(Chonnam National University Hospital), Jin Myoung Seok(Samsung Medical Center), Eun Hee Sohn(Chungnam National University), So‐Young Huh(Kosin University Gospel Hospital), Jong Kuk Kim(Dong-A University), Jun‐Soon Kim(Seoul National University Bundang Hospital), Seong‐il Oh(Kyung Hee University), Jeeyoung Oh(Université Paris-Sud), Byeol‐A Yoon(Kyungpook National University Hospital), Young Nam Kwon(Yonsei University), Sun‐Young Kim(Hanyang Cyber University), Sung‐Min Kim(Seoul National University Hospital), Jin‐Sung Park(Kyungpook National University Hospital), Sang-Gon Lee(Korea University), Myoung‐jin Jang(Seoul National University Hospital), Hye Lim Lee(Korea University Medical Center), Ju‐Hong Min(Samsung Medical Center), Young Gi Min(Seoul National University), Byoung Joon Kim(Samsung Medical Center), Kyung Seok Park(Seoul National University Hospital)
Cited by 18
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder
|Multiple Sclerosis Journal|2011|284
A New Subtype Classification of Ischemic Stroke Based on Treatment and Etiologic Mechanism
|European Neurology|2006|121
The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders
|Multiple Sclerosis Journal|2013|84
Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea
|Multiple Sclerosis Journal|2017|82